Seeking Alpha
 

Telik, Inc. (TELK)

- OTCQB
TELK is defunct.
From other sites
Visit Seeking Alpha's
Company Description
Telik is a clinical-stage biopharmaceutical company focused on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. We generate our pipeline of antibody-based product candidates from patients who have been vaccinated... More